Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use

Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use

US Patent 9932344 · Granted Apr 3, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Natural killer cells2025
Arylazo-heteroaryl compounds and their use for long-term thermal energy storage2025
Natural killer cells2025
4-ethynylpyridine derivatives useful as GCN2 inhibitors2024
4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds 2024
4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds 2024
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023